![William Fairey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Fairey
Director/Board Member at
MIRUM PHARMACEUTICALS, INC.
Net worth: 719 566 $ as of 30/08/2026
Profile
William C.
Fairey is Executive Chairman at Respira Therapeutics, Inc. since 2022.
He serves as Independent Director at Rein Therapeutics, Inc. starting in 2023, at Ascendis Pharma A since 2022, and at Mirum Pharmaceuticals, Inc. since 2021.
He is also Director at Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. Formerly, Mr. Fairey was Director at Lung Therapeutics LLC from 2021 to 2023, Independent Director at KalVista Pharmaceuticals, Inc. from 2024 to 2026, Chief Operating Officer & Executive Vice President at ChemoCentryx, Inc. from 2018 to 2019, Chief Commercial Officer & Executive VP at MyoKardia, Inc. from 2019 to 2020, Vice President-Sales & Management Markets at Actelion Pharmaceuticals US, Inc. from 2001 to 2003, President at Actelion Pharmaceuticals US, Inc. from 2013 to 2017, Regional Vice President at Australia Asia Pacific Hotels Ltd., President at Actelion Pharmaceuticals Canada, Inc. from 2003 to 2008, and Regional Vice President-Australia Asia Pacific at Actelion Pharmaceuticals Ltd. from 2008 to 2013.
Education includes an MBA from St. Mary's College of California conferred in 1994 and an undergraduate degree from the University of Oregon conferred in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASCENDIS PHARMA A/S -.--% | 17/03/2026 | 2,117 ( -.--% ) | 474 441 $ | 30/05/2026 |
| 14/06/2026 | 2,500 ( 0% ) | 245 125 $ | 30/08/2026 | |
| 12/05/2026 | 0 ( -.--% ) | - $ | 30/08/2026 |
William Fairey active positions
| Companies | Position | Start |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Director/Board Member | 18/08/2021 |
| ASCENDIS PHARMA A/S | Director/Board Member | 31/08/2022 |
| REIN THERAPEUTICS INC. | Director/Board Member | 30/10/2023 |
Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. | Director/Board Member | - |
Respira Therapeutics, Inc.
 Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Focuses on pulmonary delivery of therapeutics for respiratory diseases | Chairman | 31/12/2021 |
Former positions of William Fairey
| Companies | Position | End |
|---|---|---|
| KALVISTA PHARMA | Director/Board Member | 10/06/2026 |
Lung Therapeutics LLC
 Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Director/Board Member | 30/10/2023 |
| MYOKARDIA, INC. | Corporate Officer/Principal | 31/10/2020 |
| CHEMOCENTRYX, INC. | Chief Operating Officer | 17/01/2019 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Training of William Fairey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Lung Therapeutics LLC
Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Health Technology |
St. Mary's College of California
 St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Australia Asia Pacific Hotels Ltd.
 Australia Asia Pacific Hotels Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates hotels | Consumer Services |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Focuses on pulmonary delivery of therapeutics for respiratory diseases | Health Technology |
Actelion Pharmaceuticals Canada, Inc. | |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes molecular weight drugs | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. |
- Stock Market
- Insiders
- William Fairey
